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CASE REPORT
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Calcium channel blockers are widely used antihypertensive 
drugs, which are uncommonly associated with cutaneous 
reactions, such as pruritus, urticaria, or alopecia. Photosensi-
tivity presenting with telangiectasia has rarely been descri-
bed. We present here a case of photodistributed telangiec-
tasia induced clinically by amlodipine and histologically by 
enlarged capillaries in the upper dermis without signs of 
vasculitis. (Ann Dermatol 23(S1) S30∼S32, 2011)
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INTRODUCTION
Calcium channel blockers (CCB) are rarely associated with 
adverse skin reactions; the incidence of reactions is 8 per 
10
6 prescriptions for nifedipine and diltiazem, with reac-
tions consisting mainly of pruritus and urticaria
1. Only 
seven cases of telangiectasia appearing in photo distri-
buted areas as a result of administration of CCB have been 
reported
1-5, three of these cases were induced by amlo-
dipine
2,3,5.
CASE REPORT
A 56-year-old man presented with a two-year history of 
non-pruritic telangiectasia, which initially developed on 
the face and spread to the neck and both shoulders. His 
hypertension was treated with amlodipine for two years 
without any additional medications. He had no history of 
photosensitivity, rosacea, or use of topical steroids. Phy-
sical examination revealed asymptomatic widely distri-
buted spider-like telangiectasia on the face, V area of the 
neck, and the shoulders (Fig. 1A). Biopsy specimens taken 
from his arm revealed enlarged capillaries in the upper 
dermis without signs of vasculitis (Fig. 2). Laboratory 
studies revealed a normal total white cell count and liver 
enzymes. Due to his clear history and time consistencies 
between onset of the cutaneous reaction and admini-
stration of amlodipine, a diagnosis of photodistributed am-
lodipine induced-telangiectasia was made. Amlodipine 
was discontinued and replaced by irbesartan and thiazide. 
A remarkable improvement was observed 1 month later 
and two months later; the telangiectasia had almost faded. 
However, after 4 months, he was admitted to the hospital 
with cerebral infarct and uncontrolled hypertension. 
Amlodipine was re-administrated and the rash relapsed 
within 1 week (Fig. 1B). He has been receiving main-
tenance therapy with clopidogrel and amlodipine with 
persistent telangiectasia on the face and shoulders.
DISCUSSION
Iatrogenic telangiectasia is a poorly understood dermato-
logical side-effect, occurring secondary to administration 
of many drugs, including lithium, thiotrixene, interferon- 
alfa, and isotretinoin
6. Telangiectasia, localized to photo- 
exposed sites, has been described after administration of 
calcium channel blockers
1-5. In addition, two cases of 
photo-distributed telangiectasia resulting from cefotaxime 
and venlafaxine have been reported
6,7.Photodistributed Telangiectasia Induced by Amlodipine
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Fig. 1. (a) Spider-like telangiectasia widely distributed on the V area of the neck and both shoulders. (b) The rash was recurred after
restarting amlodipine.
Fig. 2. Skin biopsy from his arm showing dilated capillaries without inflammatory infiltrate (H&E, A: ×40, B: ×200).
CCB is the first-line therapy in treatment of hypertension. 
The three subclasses of CCB include the following: vera-
pamil, diltiazem, and dihydropyridines (amlodipine, felo-
dipines, and nifedipine). Almost all reported cases of cal-
cium channel blocker-induced telangiectasia were from 
dihydropyridines, due to their greater vascular smooth 
muscle effects relative to cardiac effects, compared with 
diltiazem and verapamil
8. CCB may provoke telangiec-
tasia by the nature of their vasodilatory action; however, it 
is not clearly understood how they may cause photo-
sensitivity. One theory is that the photoproducts created 
by UVA and visible wavelengths bind with skin proteins, 
leading to telangiectasia
2. This cutaneous reaction is regar-
ded as photosensitive; however, it does not clearly corres-JW Byun, et al
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pond to the signs and symptoms of a photoallergic or 
phototoxic reaction. 
Differential diagnosis of telangiectasia considers many 
underlying diseases, including liver disease, essential tela-
ngiectasia, scleroderma, and lupus erythematosus
5; the 
majority of these can be excluded by a careful history, 
examination, and skin biopsy. 
In summary, the photo-distributed telangiectasia observed 
in our patient, together with the considerable impro-
vement seen within two months of stopping amlodipine 
and recurrence after restarting, is clearly suggestive that 
amlodipine was the causative drug. It is important to 
consider that use of these drugs can result in acquired 
telangiectasia and prompt discontinuation may lead to 
spontaneous improvement. However, close observation 
and monitoring of blood pressure after changing these 
drugs should be required.
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